Cenobamate
Indication
Treating focal onset seizures in epilepsy (NICE TA753)
NICE TA753 - Cenobamate for treating focal onset seizures in epilepsy
Red
Brand:
Nice TA:
753
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
1.1 Cenobamate is recommended as an option for treating focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has not been adequately controlled with at least 2 antiseizure medicines. It is recommended only if:
-
it is used as an add-on treatment, after at least 1 other add-on treatment has not controlled seizures, and
-
treatment is started in a tertiary epilepsy service.